Characteristic | Total (n = 119) | |
---|---|---|
Combined cataract surgery, n (%) | 20 | 16.8% |
Duration of surgery (mins), mean (SD) | 71.9 | 23.9 |
Number of tears, mean (SD) | 2.6 | 1.8 |
One, n (%) | 40 | 33.6% |
Two, n (%) | 29 | 24.4% |
Three, n (%) | 13 | 10.9% |
Four or more, n (%) | 32 | 26.8% |
Location of tear, n (%) | ||
Supero-temporal | 65 | 54.6% |
Supero-nasal | 38 | 31.9% |
Infero-nasal | 30 | 25.2% |
Infero-temporal | 40 | 33.6% |
Number of laser shots, mean (SD) | 969.8 | 519.0 |
Q1 | 550 | |
Q2 | 843 | |
Q3 | 1323 | |
Q4 | 1776 | |
Intraoperative 360° Photocoagulation, n (%) | 84 | 70.6% |
Intraoperative ILM peeling, n (%) | 0 | 0.0% |
Intraoperative cryotherapy, n (%) | 14 | 11.8% |
Failure to cure and postoperative complications | ||
---|---|---|
ERM formation, n (%) | 69 | 58.0% |
Stage 1 | 56 | 47.1% |
Stage 2 | 9 | 7.6% |
Stage 3 | 3 | 2.5% |
Stage 4 | 1 | 0.8% |
Reoperation for ERM | 6 | 5.0% |
Mean time to reoperation for ERM, days (SD) | 488 | 351 |
PVR Grade C, n (%) | 2 | 1.7% |
Re-detachment, n (%) | 2 | 1.7% |
Macular hole, n (%) | 4 | 3.4% |
Full thickness, n (%) | 2 | 1.7% |
Lamellar, n (%) | 2 | 1.7% |
Severe macular edema a *, n (%) | 1 | 0.8% |
Subretinal perflurocarbon, n (%) | 1 | 0.8% |